Our vision is a world where every patient receives the right drugs at optimal doses. This means maximising tolerability, and pre-empting and managing adverse drug reactions. This personalised approach maximises the efficiency of treatment while improving patient quality of life.
Our world leading research has significant implications across the whole spectrum of pharmaceutical production and delivery. Most importantly it benefits the wellbeing of patients and society as a whole.